ConductScience.org, home

Paper8553567

Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.

Khanna R and 5 others. Virology, 1995. Cited by 69 papers, by iCite.

Cite this record

ConductScience Library. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance. Papers, record 8553567. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8553567

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
PubMed
Journal
Virology
PubMed
Year
1995
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
69
iCite
Relative citation ratio, by iCite
1.41
iCite
Revised in PubMed
2019-07-14
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Khanna RR
2Burrows SRS R
3Steigerwald-Mullen PMP M
4Thomson SAS A
5Kurilla MGM G
6Moss DJD J

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, ViralMajor topic
DNA-Binding ProteinsMajor topic
Herpesviridae InfectionsMajor topic
Herpesvirus 4, HumanMajor topic
Immunologic SurveillanceMajor topic
T-Lymphocytes, CytotoxicMajor topic
Tumor Virus InfectionsMajor topic
Amino Acid Sequence
Cell Line, Transformed
Cells, Cultured
Epitopes
Epstein-Barr Virus Nuclear Antigens
Humans
Molecular Sequence Data
Peptides
Virus Latency

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA-52250-04NCI NIH HHSUnited StatesPubMedPubMed
R01CA052250NIHNIH RePORTER

Download CSV of grants

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.

PMIDTitleJournalYearIn PapersSource
37553346Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing mice.Nat Commun2023https://conductscience.org/library/papers/37553346PubMed
34115118CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplant.Blood2021https://conductscience.org/library/papers/34115118PubMed
24981123Porcine reproductive and respiratory syndrome (PRRS): an immune dysregulatory pandemic.Immunol Res2014https://conductscience.org/library/papers/24981123PubMed
23569328MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response.J Exp Med2013https://conductscience.org/library/papers/23569328PubMed
22002875A clonal model for human CD8+ regulatory T cells: unrestricted contact-dependent killing of activated CD4+ T cells.Eur J Immunol2012https://conductscience.org/library/papers/22002875PubMed
21622860Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition.J Immunol2011https://conductscience.org/library/papers/21622860PubMed
20133861Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20133861PubMed
18754877Epstein-Barr virus nuclear antigen 1-specific CD4+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells.Cancer Sci2008https://conductscience.org/library/papers/18754877PubMed
17942757Repertoire and frequency of immune cells reactive to Epstein-Barr virus-derived autologous lymphoblastoid cell lines.Blood2008https://conductscience.org/library/papers/17942757PubMed
17937498Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection.PLoS Pathog2007https://conductscience.org/library/papers/17937498PubMed
17611619Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy.PLoS One2007https://conductscience.org/library/papers/17611619PubMed
16542378Selection of Epstein-Barr virus specific cytotoxic T lymphocytes can be performed with B lymphoblastoid cell lines created in serum-free media.Clin Exp Immunol2006https://conductscience.org/library/papers/16542378PubMed
16456552Characterization of an immuno 'stealth' derivative of the herpes simplex virus thymidine-kinase gene.Cancer Gene Ther2006https://conductscience.org/library/papers/16456552PubMed
15827162Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity.J Virol2005https://conductscience.org/library/papers/15827162PubMed
15795275CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines.J Virol2005https://conductscience.org/library/papers/15795275PubMed
15314691Critical role of EBNA1-specific CD4+ T cells in the control of mouse Burkitt lymphoma in vivo.J Clin Invest2004https://conductscience.org/library/papers/15314691PubMed
14769850Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes.J Exp Med2004https://conductscience.org/library/papers/14769850PubMed
14581546Cytolytic CD4(+)-T-cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-cell proliferation.J Virol2003https://conductscience.org/library/papers/14581546PubMed
14566361Creation of immune 'stealth' genes for gene therapy through fusion with the Gly-Ala repeat of EBNA-1.Gene Ther2003https://conductscience.org/library/papers/14566361PubMed
12828556Retroviral transfer of T-cell receptor genes produces cells with a broad range of lytic activity.Scand J Immunol2003https://conductscience.org/library/papers/12828556PubMed

See all 29 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8553567

GET https://conductscience.org/api/papers/v1/8553567/cited_by?page=2